Liraglutide, a long-acting human glucagon-like peptide-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes.
- Resource Type
- Academic Journal
- Source
Diabetes Care (DIABETES CARE), Jun2007; 30(6): 1608-1610. (3p)- Subject
- Language
- English
- ISSN
- 0149-5992